Bioprocessing
Thermo Fisher expands COVID-19 therapies, vaccines
Thermo Fisher Scientific is expanding the development and production of COVID-19 vaccines, therapies, and additional treatments.
Faster fluid mixing could reduce costs for silica microparticles
A surprisingly simple approach to manufacturing silica nanoparticles by taking advantage of fluid dynamics in tiny Teflon tubes could reduce manufacturing costs. The work is described in a June 28 article published in the Chemical Engineering Journal.  Discuss
Avantor expands its innovation center for bioprocessing
Avantor is increasing its investment in bioprocessing infrastructure by expanding its innovation center in Bridgewater, NJ.
MaxCyte launches Expert cell engineering products
Cell-based medicines and life sciences company MaxCyte has launched a new line of disposable cell engineering products.
New consortium formed to develop cell-based cancer vaccines
A new consortium has been formed to increase access to cell-based cancer vaccines by using single-use technology to develop and manufacture dendritic cell cancer vaccines.
Need for efficiency, COVID-19 vaccine spurs biomanufacturing in 2020
With the urgent need for COVID-19 therapies and vaccines, funding agencies have prioritized biomanufacturing; companies in turn are preparing to ramp up a variety of biologics. The strong demand for bioprocessed medicines in 2020 will continue to drive growth of the industry.  Discuss
U.S. launches project to promote pharma manufacturing
The U.S. Department of Health and Human Services on May 19 announced a new project to promote U.S.-based pharmaceutical manufacturing to secure the supply of essential medicines during crises like the COVID-19 pandemic. The project includes a $354 million contract with Phlow of Richmond, VA.  Discuss
Thermo Fisher gets U.S. contract for COVID-19 sample collection
Thermo Fisher Scientific announced that it has received a contract from the U.S. government to provide highly specialized viral transport media for COVID-19 sample collection. To fulfill the contract, the company will expand capacity with a $40 million facility.
Glenmark begins phase III trials for favipiravir
Glenmark has launched phase III clinical trials in India to assess the use of its favipiravir antiviral tablets on COVID-19 patients. The drug is a generic version of Fujifilm Toyama Chemical's Avigan.
Gilead licenses remdesivir to increase global access
Gilead Sciences has inked several agreements for the manufacture and distribution of remdesivir, which has been issued an emergency use authorization by the U.S. Food and Drug Administration (FDA) on May 1.
Conferences
2020 ACCP Annual Meeting
September 20-22
Bethesda, Maryland United States
Bioprocess International West
September 21-24
Eastern Standard Time Zone (EST) United States
BioProcess International
September 21-24
Eastern Standard Time Zone (EST), Massachusetts United States
General Discussion
Topic Replies / Views Last Update
Childhood vaccines may help protect against COVID-19 mortality
by Ratcatcher
0 / 6 More than 3 days ago
by Ratcatcher
https://academic.oup.com/ve/pages/coronavirus-evolution
by Michael
0 / 49 More than 3 days ago
by Michael
PopSci Hails Impossible Burger 2.0 as Most Important Engineering Innovation in 2019
by Mahesh Gupta
0 / 14 More than 3 days ago
by Mahesh Gupta
Engineered Bacteria Produces BeeFree Honey
by Mahesh Gupta
0 / 13 More than 3 days ago
by Mahesh Gupta
Consumers' Preference to Buy Unlabeled Produce Increases after Exposure to GMO-labeled Pro
by Mahesh Gupta
0 / 15 More than 3 days ago
by Mahesh Gupta
To see more posts from our community or to share a post of your own, go to our community's forum page.
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter